-
Loading metrics
A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma
- Fernando Alegre,
- Amanda R. Ormonde,
- Kellie M. Snider,
- Kevin Woolard,
- Ai-Ming Yu,
- Luke A. Wittenburg
x
- Published: December 31, 2018
- https://doi.org/10.1371/journal.pone.0209941